Published in J Neurol on November 13, 2010
Mitochondrial vasculopathy. World J Cardiol (2016) 0.98
Mitochondrial m.3243A > G mutation and carotid artery dissection. Mol Genet Metab Rep (2016) 0.94
Macroangiopathy is a typical phenotypic manifestation of MELAS. Metab Brain Dis (2017) 0.75
A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature (1990) 7.89
Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol (2009) 3.02
Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol (1987) 1.92
Management of mitochondrial stroke-like-episodes. Eur J Neurol (2009) 1.32
Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol (2006) 1.29
Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Ann Neurol (1993) 0.95
Aortic rupture in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. Arch Neurol (2006) 0.93
CADISP-genetics: an International project searching for genetic risk factors of cervical artery dissections. Int J Stroke (2009) 0.81
Vascular involvement in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Am J Med Sci (2005) 0.78
A new paradigm for translational control: inhibition via 5'-3' mRNA tethering by Bicoid and the eIF4E cognate 4EHP. Cell (2005) 2.80
Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J (2011) 1.65
Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS (2007) 1.62
Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology (2003) 1.56
Cap-dependent translational inhibition establishes two opposing morphogen gradients in Drosophila embryos. Curr Biol (2006) 1.47
Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article. J Neurosurg (2013) 1.46
Use of modafinil in patients with epilepsy. Epilepsy Behav (2012) 1.42
Somatic mutations of the ERBB4 kinase domain in human cancers. Int J Cancer (2006) 1.38
BRAF and KRAS mutations in stomach cancer. Oncogene (2003) 1.27
A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care (2011) 1.22
CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res (2005) 1.20
Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas. Virchows Arch (2005) 1.20
Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene (2005) 1.09
Loss of caspase-2, -6 and -7 expression in gastric cancers. APMIS (2004) 1.06
Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS (2003) 1.05
Somatic mutations of CASP3 gene in human cancers. Hum Genet (2004) 1.05
Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas. Oncology (2006) 1.00
Propagation of epileptic spikes reconstructed from spatiotemporal magnetoencephalographic and electroencephalographic source analysis. Neuroimage (2009) 0.98
Rescue of pituitary function in a mouse model of isolated growth hormone deficiency type II by RNA interference. Endocrinology (2007) 0.97
Inactivating mutations of CASPASE-7 gene in human cancers. Oncogene (2003) 0.96
Primary Classic Kaposi's Sarcoma of the Penis in an HIV-Negative Patient. Korean J Urol (2010) 0.95
Absence of MLL3 mutations in colorectal carcinomas of Korean patients. APMIS (2007) 0.93
ERBB3 kinase domain mutations are rare in lung, breast and colon carcinomas. Int J Cancer (2006) 0.92
Alterations of Fas-pathway genes associated with nodal metastasis in non-small cell lung cancer. Oncogene (2002) 0.92
The utility of conductive plastic electrodes in prolonged ICU EEG monitoring. Neurocrit Care (2008) 0.88
Inactivating mutation of the pro-apoptotic gene BID in gastric cancer. J Pathol (2004) 0.88
Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer. Int J Cancer (2005) 0.86
A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci (2003) 0.86
Colorectal tumors frequently express phosphorylated mitogen-activated protein kinase. APMIS (2004) 0.85
Impact of pediatric epilepsy on sleep patterns and behaviors in children and parents. Epilepsia (2012) 0.84
Expression and immunohistochemical localization of TMEM16A/anoctamin 1, a calcium-activated chloride channel in the mouse cochlea. Cell Tissue Res (2011) 0.83
Immunohistochemical and mutational analysis of apoptosis-inducing factor (AIF) in colorectal carcinomas. APMIS (2006) 0.83
Diurnal pattern of seizures outside the hospital: is there a time of circadian vulnerability? Neurology (2012) 0.82
Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients. Epilepsy Behav (2010) 0.82
BH3 domain mutation of proapoptotic genes Bad, Bmf and Bcl-G is rare in transitional cell carcinomas of the urinary bladder. Pathology (2006) 0.81
Mutational analysis of Noxa gene in human cancers. APMIS (2003) 0.81
Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas. APMIS (2006) 0.80
Mutational analysis of PDPK1 kinase domain in gastric, colorectal and lung carcinomas. Acta Oncol (2006) 0.80
Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers. Pathol Res Pract (2007) 0.80
Kinase domain mutation of ERBB family genes is uncommon in acute leukemias. Leuk Res (2005) 0.79
Kaposi's Sarcoma-Associated Herpesvirus-Related Solid Lymphoma Involving the Heart and Brain. AIDS Res Treat (2011) 0.79
Mutational analysis of the kinase domain of MYLK2 gene in common human cancers. Pathol Res Pract (2006) 0.78
Mitochondrial microsatellite instability of colorectal cancer stroma. Int J Cancer (2006) 0.78
Current dipole orientation and distribution of epileptiform activity correlates with cortical thinning in left mesiotemporal epilepsy. Neuroimage (2010) 0.78
Absence of GNAS and EGFL6 mutations in common human cancers. Pathology (2008) 0.78
Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas. J Neurooncol (2012) 0.78
Absence of DKC1 exon 3 mutation in common human cancers. Acta Oncol (2006) 0.77
Quantitative EEG in hospital encephalopathy: review and microstate analysis. J Clin Neurophysiol (2013) 0.77
Somatic mutation of pro-apoptosis caspase-6 gene is rare in breast and lung carcinomas. Pathology (2006) 0.77
Seizure control: a secondary benefit of chemotherapeutic temozolomide in brain cancer patients. Epilepsy Res (2011) 0.76
Absence of JAK2 V617F mutation in gastric cancers. Acta Oncol (2006) 0.76
Levetiracetam versus phenytoin: a comparison of efficacy of seizure prophylaxis and adverse event risk following acute or subacute subdural hematoma diagnosis. Neurocrit Care (2014) 0.76
Defining and Validating the Salzburg Criteria: It's Complicated. Epilepsy Curr (2017) 0.75
Frontal Focal Cortical Dysplasias: Too Thin Here, Too Thick There, and the Folding Just Isn't Right! Epilepsy Curr (2016) 0.75
Nonconvulsive Seizures and Periodic Discharges: No Longer Such Innocent Bystanders. Epilepsy Curr (2016) 0.75
Methylphenidate: Brain Gain for the Epilepsy Drain. Epilepsy Curr (2017) 0.75
Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer. APMIS (2003) 0.75
Fruitful Futility: What We Learned From a Failed Clinical Trial of Out-of-Hospital Status Epilepticus Trial. Epilepsy Curr (2016) 0.75
Kinase domain mutation of MAP2K4 is rare in gastric, colorectal and lung carcinomas. Pathology (2006) 0.75
Seizures and antiepileptic drugs in patients with spontaneous intracerebral hemorrhages. Seizure (2013) 0.75
Variation of ZnO shell thickness and its effects on the characteristics of coaxial nanowires. Nanotechnology (2008) 0.75
Mutational analysis of P-loop domains of proapoptotic Nod1 and ARTS genes in colon carcinomas. Acta Oncol (2006) 0.75
Antiemetic properties of the antiepileptic drug levetiracetam. N Engl J Med (2008) 0.75
Absence of the mutation of serine/threonine kinase genes AKT2 and MYLK2 in acute leukemias. Eur J Haematol (2006) 0.75
Effect of surface roughness on the subsequent growth of MgO nanowires. J Nanosci Nanotechnol (2008) 0.75
Mutating Our Understanding of Brain Tumors and Seizures: Entrez IDH. Epilepsy Curr (1) 0.75
Mutational analysis of salvador gene in human carcinomas. APMIS (2003) 0.75
Fabrication of gold nanotubes from removable MgO nanowires templates. J Nanosci Nanotechnol (2008) 0.75
Delayed Seizures and Poor Functional Outcome After Intracranial Hemorrhage Is the Fate of Patients with a Poor Underlying Substrate, Say the Intensivists. Epilepsy Curr (2017) 0.75
Sn-catalyzed growth of MgO nanowires. J Nanosci Nanotechnol (2007) 0.75
Mutational analysis of Fas ligand gene in human non-Hodgkin lymphoma. APMIS (2003) 0.75
hCDC4 gene mutation is rare in colorectal carcinomas in Korean patients. Pathology (2008) 0.75
Absence of fusion of TMPRSS2 and ETS transcription factor genes in gastric and colorectal carcinomas. APMIS (2007) 0.75
Absence of the ERBB2 kinase domain mutation in lung adenocarcinomas in Korean patients. Int J Cancer (2005) 0.75
Absence of the BH3 domain mutation of proapoptotic Bcl-2 family gene BAD in serous and mucinous tumors of ovary. Gynecol Oncol (2006) 0.75
Effects of thermal annealing on Pt-shell/MgO-core nanowires. J Nanosci Nanotechnol (2009) 0.75
Kinase domain mutation of NTRK3 gene is uncommon in gastric carcinomas. Acta Oncol (2005) 0.75
Mutation of FADD gene is rare in human colon and stomach cancers. APMIS (2004) 0.75